SCHEMBL7578243

SCHEMBL7578243

OC(Cc1ccccc1)c1ccco1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MIF P14174 1/20 0.59
SLC5A2 P31639 1/20 0.51
HSD17B10 Q99714 2/20 0.50
NPSR1 Q6W5P4 2/20 0.50
USP2 O75604 1/20 0.50
ALOX15 P16050 1/20 0.50
POLB P06746 3/20 0.48
KMT2A Q03164 3/20 0.48
MEN1 O00255 2/20 0.48
AGTR1 P30556 1/20 0.48
L3MBTL1 Q9Y468 3/20 0.48
PKM P14618 2/20 0.48
PTPN1 P18031 1/20 0.48
PTPN7 P35236 1/20 0.48
BLM P54132 1/20 0.48
ESR2 Q92731 1/20 0.48
GAA P10253 1/20 0.47
SMN1; SMN2 Q16637 2/20 0.44
MAPT P10636 2/20 0.44
HPGD P15428 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9764695 1.00 MIF (0.59) MIFSLC5A2HSD17B10NPSR1USP2
SCHEMBL19389795 0.84 MIF (0.45) MIFSLC5A2HSD17B10NPSR1USP2
SCHEMBL29636345 0.82 KMT2A (0.49) MIFSLC5A2HSD17B10NPSR1USP2
SCHEMBL23089936 0.81 KMT2A (0.47) MIFSLC5A2HSD17B10NPSR1USP2
SCHEMBL14548551 0.80 ENPP2 (0.44) MIFSLC5A2HSD17B10NPSR1USP2
SCHEMBL14548679 0.80 KMT2A (0.42) MIFSLC5A2HSD17B10NPSR1USP2
SCHEMBL7319840 0.80 MIF (0.51) MIFHSD17B10POLBKMT2AMEN1
SCHEMBL7319842 0.80 MIF (0.51) MIFHSD17B10POLBKMT2AMEN1
SCHEMBL7319847 0.80 MIF (0.51) MIFHSD17B10POLBKMT2AMEN1
SCHEMBL23615482 0.78 OPRM1 (0.45) MIFSLC5A2POLBKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111868105-B Photopolymerizable sensitizer composition 川崎化成工业株式会社 2022-05-13 CN claimed
JP-54098767-A None JP disclosed
US-11578079-B2 SUMO inhibitor compounds and uses thereof CITY OF HOPE (US) 2023-02-14 US disclosed
US-11352450-B2 Photopolymerization sensitizer composition KAWASAKI KASEI CHEMICALS LTD. (JP) 2022-06-07 US disclosed
CN-111868105-B Photopolymerizable sensitizer composition 川崎化成工业株式会社 2022-05-13 CN disclosed
US-20210079127-A1 PHOTOPOLYMERIZATION SENSITIZER COMPOSITION KAWASAKI KASEI CHEMICALS LTD. (JP) 2021-03-18 US disclosed
CN-111868105-A Photopolymerizable sensitizer composition 川崎化成工业株式会社 2020-10-30 CN disclosed
WO-2020028525-A1 SUMO INHIBITOR COMPOUNDS AND USES THEREOF CITY OF HOPE (US) 2020-02-06 WO disclosed
CN-107722068-A Three tooth aminophosphine ligands and its complex and its application in the asymmetric catalytic hydrogenation of ketone 凯特立斯(深圳)科技有限公司 2018-02-23 CN disclosed
WO-2002098853-A2 INHIBITORS OF CELL PROLIFERATION, ANGIOGENESIS, FERTILITY, AND MUSCLE CONTRACTION THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2002-12-12 WO disclosed
US-4870100-A INSECTICIDES BASF AKTIENGESELLSCHAFT (DE) 1989-09-26 US disclosed
US-4496767-A REARRANGEMENT, ESTERIFICATION AND REDUCTION OF A FURAN-CARBINOL SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1985-01-29 US disclosed
US-4246178-A CHEMICAL INTERMEDIATE FOR THE FLAVOR MALTOL SHIN-ETSU CHEMICAL CO., LTD. (JP) 1981-01-20 US disclosed
JP-S5498767-A PREPARATION OF 3-HYDROXY-4-PYRONE COMPOUND SHIN ETSU CHEM CO LTD 1979-08-03 JP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11578079-B2 SUMO inhibitor compounds and uses thereof SUMO1, SUMO2, UBE2I MIF 2401/4885SLC5A2 4662/4885HSD17B10 848/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.